Therefore, pharmacologically-safe anti-tumor agents with the potential to influence the tumor microenvironment and inhibit NF-κB signaling activation may enhance chemosensitivity and reduce metastasis of tumor cells and provide a promising approach for the prevention or treatment of tumors. This evidence concerns the gene NFKB1 and neoplasm.